We have been informed that there is an ongoing shortage of salbutamol solutions for nebulisers that is likely to last until summer 2024. If you live in Greater Manchester and you have COPD or asthma your GP has been provided with guidelines to ensure that any impact on your care is minimised, and your GP will be able to advise you further.
GPs elsewhere in the UK will also need to prepare, and update your action plan accordingly.
If at all concerned contact your GP for advice, as all should be aware of this situation.
Share this post
Path:
Start » Living with Aspergillosis » General interest » Salbutamol nebuliser solution shortage
Latest News posts
🔬 Charcot–Leyden Crystals in ABPA and Asthma
February 13, 2026
Event: 📸 Science is Open: A Photo Journey of Research Lab Samples
February 12, 2026
How to Join Our Microsoft Teams Meetings – Troubleshooting
February 12, 2026
Health effects: why aspergillosis patients are higher-risk
February 10, 2026
Damp, mould and aspergillosis in rented homes (UK)
February 10, 2026
Recognising a damp or mouldy home
February 10, 2026
Your rights, the law, and UK support organisations
February 10, 2026
Remediation, verification, and refusal to move you
February 10, 2026
How to raise damp and mould with your landlord (and get action)
February 10, 2026
News archive
× Close
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
